ID   B3GLT_HUMAN             Reviewed;         498 AA.
AC   Q6Y288; A8K5F8; Q5W0H2; Q6NUI3;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   10-MAY-2017, entry version 113.
DE   RecName: Full=Beta-1,3-glucosyltransferase;
DE            Short=Beta3Glc-T;
DE            EC=2.4.1.-;
DE   AltName: Full=Beta 3-glucosyltransferase {ECO:0000312|HGNC:HGNC:20207};
DE   AltName: Full=Beta-3-glycosyltransferase-like;
GN   Name=B3GLCT {ECO:0000312|HGNC:HGNC:20207}; Synonyms=B3GALTL, B3GTL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT LYS-370.
RX   PubMed=12943678; DOI=10.1016/S0006-291X(03)01540-7;
RA   Heinonen T.Y.K., Pasternack L., Lindfors K., Breton C., Gastinel L.N.,
RA   Maeki M., Kainulainen H.;
RT   "A novel human glycosyltransferase: primary structure and
RT   characterization of the gene and transcripts.";
RL   Biochem. Biophys. Res. Commun. 309:166-174(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME ACTIVITY, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, MUTAGENESIS OF 495-ARG--LEU-498, AND
RP   VARIANT LYS-370.
RX   PubMed=16899492; DOI=10.1093/glycob/cwl035;
RA   Sato T., Sato M., Kiyohara K., Sogabe M., Shikanai T., Kikuchi N.,
RA   Togayachi A., Ishida H., Ito H., Kameyama A., Gotoh M., Narimatsu H.;
RT   "Molecular cloning and characterization of a novel human beta1,3-
RT   glucosyltransferase, which is localized at the endoplasmic reticulum
RT   and glucosylates O-linked fucosylglycan on thrombospondin type 1
RT   repeat domain.";
RL   Glycobiology 16:1194-1206(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LYS-370.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT LYS-370.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INVOLVEMENT IN PPLS.
RX   PubMed=16909395; DOI=10.1086/507567;
RA   Lesnik Oberstein S.A., Kriek M., White S.J., Kalf M.E., Szuhai K.,
RA   den Dunnen J.T., Breuning M.H., Hennekam R.C.M.;
RT   "Peters plus syndrome is caused by mutations in B3GALTL, a putative
RT   glycosyltransferase.";
RL   Am. J. Hum. Genet. 79:562-566(2006).
CC   -!- FUNCTION: O-glucosyltransferase that transfers glucose toward
CC       fucose with a beta-1,3 linkage. Specifically glucosylates O-linked
CC       fucosylglycan on TSP type-1 domains of proteins, thereby
CC       contributing to elongation of O-fucosylglycan.
CC       {ECO:0000269|PubMed:16899492}.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000255|PROSITE-ProRule:PRU10138,
CC       ECO:0000269|PubMed:16899492}; Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:16899492}.
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest levels in
CC       testis and uterus. {ECO:0000269|PubMed:12943678,
CC       ECO:0000269|PubMed:16899492}.
CC   -!- DISEASE: Peters-plus syndrome (PPLS) [MIM:261540]: Autosomal
CC       recessive disorder characterized by anterior eye-chamber
CC       abnormalities, disproportionate short stature, developmental
CC       delay, characteristic craniofacial features, cleft lip and/or
CC       palate. {ECO:0000269|PubMed:16909395}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 31 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY190526; AAO37647.1; -; mRNA.
DR   EMBL; AB101481; BAD13528.1; -; mRNA.
DR   EMBL; AK291273; BAF83962.1; -; mRNA.
DR   EMBL; AL137142; CAI12432.2; -; Genomic_DNA.
DR   EMBL; AL138965; CAI12432.2; JOINED; Genomic_DNA.
DR   EMBL; AL138965; CAH73049.2; -; Genomic_DNA.
DR   EMBL; AL137142; CAH73049.2; JOINED; Genomic_DNA.
DR   EMBL; CH471075; EAX08483.1; -; Genomic_DNA.
DR   EMBL; BC068595; AAH68595.1; -; mRNA.
DR   CCDS; CCDS9341.1; -.
DR   RefSeq; NP_919299.3; NM_194318.3.
DR   UniGene; Hs.13205; -.
DR   ProteinModelPortal; Q6Y288; -.
DR   SMR; Q6Y288; -.
DR   BioGrid; 126890; 19.
DR   IntAct; Q6Y288; 4.
DR   STRING; 9606.ENSP00000343002; -.
DR   CAZy; GT31; Glycosyltransferase Family 31.
DR   iPTMnet; Q6Y288; -.
DR   PhosphoSitePlus; Q6Y288; -.
DR   SwissPalm; Q6Y288; -.
DR   BioMuta; B3GALTL; -.
DR   DMDM; 116243011; -.
DR   EPD; Q6Y288; -.
DR   MaxQB; Q6Y288; -.
DR   PaxDb; Q6Y288; -.
DR   PeptideAtlas; Q6Y288; -.
DR   PRIDE; Q6Y288; -.
DR   Ensembl; ENST00000343307; ENSP00000343002; ENSG00000187676.
DR   GeneID; 145173; -.
DR   KEGG; hsa:145173; -.
DR   UCSC; uc010aaz.4; human.
DR   CTD; 145173; -.
DR   DisGeNET; 145173; -.
DR   GeneCards; B3GLCT; -.
DR   GeneReviews; B3GALTL; -.
DR   H-InvDB; HIX0011217; -.
DR   HGNC; HGNC:20207; B3GLCT.
DR   HPA; HPA017664; -.
DR   MalaCards; B3GLCT; -.
DR   MIM; 261540; phenotype.
DR   MIM; 610308; gene.
DR   neXtProt; NX_Q6Y288; -.
DR   OpenTargets; ENSG00000187676; -.
DR   Orphanet; 709; Peters plus syndrome.
DR   PharmGKB; PA144596515; -.
DR   eggNOG; ENOG410IE18; Eukaryota.
DR   eggNOG; ENOG410XWFG; LUCA.
DR   GeneTree; ENSGT00530000063264; -.
DR   HOGENOM; HOG000007375; -.
DR   HOVERGEN; HBG059386; -.
DR   InParanoid; Q6Y288; -.
DR   KO; K13675; -.
DR   OMA; KIAWLVI; -.
DR   OrthoDB; EOG091G09KK; -.
DR   PhylomeDB; Q6Y288; -.
DR   TreeFam; TF313496; -.
DR   Reactome; R-HSA-5173214; O-glycosylation of TSR domain-containing proteins.
DR   UniPathway; UPA00378; -.
DR   GeneWiki; B3GALTL; -.
DR   GenomeRNAi; 145173; -.
DR   PRO; PR:Q6Y288; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000187676; -.
DR   CleanEx; HS_B3GALTL; -.
DR   Genevisible; Q6Y288; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016757; F:transferase activity, transferring glycosyl groups; TAS:Reactome.
DR   GO; GO:0006004; P:fucose metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0036066; P:protein O-linked fucosylation; TAS:Reactome.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR003378; Fringe-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   Pfam; PF02434; Fringe; 2.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS00014; ER_TARGET; 1.
PE   1: Evidence at protein level;
KW   Carbohydrate metabolism; Complete proteome;
KW   Congenital disorder of glycosylation; Endoplasmic reticulum;
KW   Fucose metabolism; Glycoprotein; Glycosyltransferase; Membrane;
KW   Polymorphism; Reference proteome; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    498       Beta-1,3-glucosyltransferase.
FT                                /FTId=PRO_0000252399.
FT   TOPO_DOM      1      6       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      7     27       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     28    498       Lumenal. {ECO:0000255}.
FT   MOTIF       495    498       Prevents secretion from ER.
FT   CARBOHYD    336    336       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     370    370       E -> K (in dbSNP:rs1041073).
FT                                {ECO:0000269|PubMed:12943678,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:16899492,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_027849.
FT   MUTAGEN     495    498       Missing: Abolishes endoplasmic reticulum
FT                                localization.
FT                                {ECO:0000269|PubMed:16899492}.
FT   CONFLICT    284    284       I -> M (in Ref. 6; AAH68595).
FT                                {ECO:0000305}.
SQ   SEQUENCE   498 AA;  56564 MW;  CDC6A479A1564D48 CRC64;
     MRPPACWWLL APPALLALLT CSLAFGLASE DTKKEVKQSQ DLEKSGISRK NDIDLKGIVF
     VIQSQSNSFH AKRAEQLKKS ILKQAADLTQ ELPSVLLLHQ LAKQEGAWTI LPLLPHFSVT
     YSRNSSWIFF CEEETRIQIP KLLETLRRYD PSKEWFLGKA LHDEEATIIH HYAFSENPTV
     FKYPDFAAGW ALSIPLVNKL TKRLKSESLK SDFTIDLKHE IALYIWDKGG GPPLTPVPEF
     CTNDVDFYCA TTFHSFLPLC RKPVKKKDIF VAVKTCKKFH GDRIPIVKQT WESQASLIEY
     YSDYTENSIP TVDLGIPNTD RGHCGKTFAI LERFLNRSQD KTAWLVIVDD DTLISISRLQ
     HLLSCYDSGE PVFLGERYGY GLGTGGYSYI TGGGGMVFSR EAVRRLLASK CRCYSNDAPD
     DMVLGMCFSG LGIPVTHSPL FHQARPVDYP KDYLSHQVPI SFHKHWNIDP VKVYFTWLAP
     SDEDKARQET QKGFREEL
//
